Audit 376628

FY End
2025-06-30
Total Expended
$8.56M
Findings
0
Programs
22
Year: 2025 Accepted: 2025-12-19
Auditor: RSM US LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.837 CARDIOVASCULAR DISEASES RESEARCH $1.45M Yes 0
47.074 BIOLOGICAL SCIENCES $365,814 Yes 0
81.049 OFFICE OF SCIENCE FINANCIAL ASSISTANCE PROGRAM $243,611 Yes 0
93.865 CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH $208,988 Yes 0
93.310 TRANS-NIH RESEARCH SUPPORT $133,476 Yes 0
47.049 MATHEMATICAL AND PHYSICAL SCIENCES $131,003 Yes 0
93.351 RESEARCH INFRASTRUCTURE PROGRAMS $130,807 Yes 0
93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH $130,186 Yes 0
93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING $98,203 Yes 0
47.041 ENGINEERING $68,379 Yes 0
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $63,035 Yes 0
12.000 DEFENSE ADVANCED RESEARCH PROJECTS AGENCY $41,795 Yes 0
93.866 AGING RESEARCH $40,609 Yes 0
12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT $36,552 Yes 0
93.867 VISION RESEARCH $30,798 Yes 0
93.397 CANCER CENTERS SUPPORT GRANTS $28,569 Yes 0
93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH $11,207 Yes 0
93.395 CANCER TREATMENT RESEARCH $9,666 Yes 0
47.070 COMPUTER AND INFORMATION SCIENCE AND ENGINEERING $9,502 Yes 0
93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS $8,692 Yes 0
93.U01 NATIONAL INSTITUTES OF HEALTH $7,161 Yes 0
93.396 CANCER BIOLOGY RESEARCH $6,525 Yes 0

Contacts

Name Title Type
W6Q8XJV41Z98 Kathi Stanek Auditee
6083164016 William O'Brien Auditor
No contacts on file

Notes to SEFA

The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of Morgridge Institute for Research, Inc. (the Institute) under programs of the federal government for the year ended June 30, 2025. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Institute, it is not intended to, and does not, present the financial position, changes in net assets, or cash flows of the Institute.
Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
The Institute did not use the de minimis cost rate. The Institute has elected to use their federally negotiated indirect cost rate for federal awards and therefore will not elect to use the 10 percent de minimis indirect cost rate.
The Institute did not receive any noncash assistance during the year ended June 30, 2025. The Institute did not have any federal insurance in effect during the year ended June 30, 2025, nor were there any loans or loan guarantees at year-end.